Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Martin Varsavsky
AddedMar 31, 2024
UpdatedJun 28, 2026
Martin Varsavsky

Martin Varsavsky

Founder, VAS Ventures

CrunchbaseLinkedIn

Martin Varsavsky's Career

VAS Ventures
VAS Ventures

Madrid, Community of Madrid, ES

Founder
Axel Springer Digital Ventures
Axel Springer Digital Ventures

Berlin, Berlin, DE

Board Member· Board
Overture Life
Overture Life

New York City, NY, US

Board Member· Board
Gameto
Gameto

New York City, NY, US

Board Member· Board
Prelude Fertility
Prelude Fertility

Atlanta, GA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Martin Varsavsky's Career

VAS Ventures
VAS Ventures
Investment FirmInvestment Firm52017Madrid, Community of Madrid, ES
Founder
Axel Springer Digital Ventures
Axel Springer Digital Ventures
Public$500M15k2012Berlin, Berlin, DE
Board Member· Board

Leadership at Axel Springer Digital Ventures

Jan BayerJan BayerBoard Member
Julian DeutzJulian DeutzBoard Member
Wolfgang ReitzleWolfgang ReitzleBoard Member
Uli SchmitzUli SchmitzCo-Founder
Andreas WieleAndreas WieleBoard Member
Mathias DöpfnerMathias DöpfnerBoard Member
Overture Life
Overture Life
Series B$45M422017New York City, NY, US
Board Member· Board

Leadership at Overture Life

Santiago MunneSantiago MunneCo-Founder
Kristina SimmonsKristina SimmonsCo-Founder
Gameto
Gameto
Series B$40M372020New York City, NY, US
Board Member· Board

Leadership at Gameto

Dina RadenkovicDina RadenkovicCo-Founder
Pranam ChatterjeePranam ChatterjeeCo-Founder

Similar to Gameto

Granata BioGranata BioDuxbury, MA, USBiopharmaceuticalsest. 2018Granata BioDuxbury, MA, US · est. 2018

Fertility biotech firm specializing in innovative solutions for patients.

Series A · $14.1M5
JumpStart FertilityJumpStart FertilityNewton, MA, USDrug Treatmentsest. 2017JumpStart FertilityNewton, MA, US · est. 2017

Jumpstart Fertility, Inc.: Pioneering drug treatments to improve egg cell quality and reverse female infertility.

Seed · $500k6
Conceivable Life SciencesConceivable Life SciencesNew York City, NY, USFertility Treatmentsest. 2022Conceivable Life SciencesNew York City, NY, US · est. 2022

Conceivable Life Sciences: Automating IVF labs for accessible fertility treatments.

Seed · $20M12
MicrogenesisMicrogenesisSan Francisco, CA, USFertility Testest. 2019MicrogenesisSan Francisco, CA, US · est. 2019

Microgenesis offers a unique fertility test and natural nutritional supplementation, enhancing women's fertility potential globally.

Pre-Seed · $2.3M14
Prelude Fertility
Prelude Fertility
Private Equity$200M7502016Atlanta, GA, US
Board Member· Board

Similar to Prelude Fertility

US FertilityUS FertilityRockville, MD, USDigital Solutions, Fertility Careest. 2020US FertilityRockville, MD, US · est. 2020

US Fertility: Physician-led innovators enhancing fertility care through advanced business and digital solutions.

Angel1.1k
Hera FertilityHera FertilityClaymont, DE, USFertility Services, Telemedicineest. 2022Hera FertilityClaymont, DE, US · est. 2022

Digital fertility company offering convenient, affordable, and personalized telemedicine services for empowered parenthood journey.

Pre-Seed · $170k7
Future FamilyFuture FamilySan Francisco, CA, USFertility Careest. 2016Future FamilySan Francisco, CA, US · est. 2016

Future Family: Affordable, personalized fertility care through subscription IVF and egg freezing.

Series B · $148.2M80
Global Premier FertilityGlobal Premier FertilityIrvine, CA, USFertility Managementest. 2018Global Premier FertilityIrvine, CA, US · est. 2018

Global Premier Fertility: Empowering independent fertility practices with expert management resources.

Series A · $11M16

Martin Varsavsky's Co-Investors

David GarcíaDavid GarcíaCo-invested · Betterness SeedCarlos DomingoCarlos DomingoCo-invested · Betterness SeedSimon ClausenSimon ClausenCo-invested · Animoca Brands Post Ipo EquityRoman KirschRoman KirschCo-invested · Animoca Brands Late Stage PrivateClément BENOITClément BENOITCo-invested · Animoca Brands Late Stage PrivateAlexander LuikAlexander LuikCo-invested · Animoca Brands Late Stage PrivateJustin SunJustin SunCo-invested · Animoca Brands Series UnknownAlexis BonteAlexis BonteCo-invested · Animoca Brands Post Ipo Equity

Martin Varsavsky's Similar Executives & Operators

Soemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakWillix HalimWillix HalimCEO · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakHaeil YiHaeil YiCo-Founder · DunamuLee Sirg-OoLee Sirg-OoCEO · Dunamu

People Similar to Martin Varsavsky

Stefan KrauseStefan KrauseBoard Member · Velo3DKevin WeathermanKevin WeathermanCEO · FacetIgor GourariIgor GourariFounder · LEVJohn MizziJohn MizziCo-Founder · Vero TechnologiesJohn EspeyJohn EspeyCo-Founder & CEO · Defiance VenturesSteven PetrevskiSteven PetrevskiBoard Member · Converge